Director: Eli Perencevich, M.D., M.S.
About the COIN
CADRE's mission is to develop, implement and test innovative strategies that expand access to high-quality primary and specialty care, while ensuring that the care delivered is safe and free of preventable infections.
Focused Areas of Research
Improving Access to High-Quality Care
Improving access to high-quality care is one of VA Secretary Shinseki's four strategic goals and is a unifying CADRE theme. To address access, CADRE
focuses on four high-impact target areas:
builds upon the strengths of Center investigators and an existing partnership with the VA Office of Rural Health through the Veterans Rural Health
Resource Center, Central Region.
is an area in which VA is challenged to meet demand and where CADRE is testing innovative approaches to delivering care using tele-health and e-health
is a high-priority area for VA due to the increasing numbers of women Veterans and their distinct healthcare needs, and is an area in which CADRE
investigators have conducted seminal work.
targets the high proportion of Veterans who use both VA and non-VA services and addresses the formidable challenges of providing seamless care across
VA and non-VA providers.
Preventing Healthcare-Associated Infections (HAI)
In the past 20 years, the incidence of HAIs has increased 36%. Approximately two million patients develop these largely preventable infections, and nearly
100,000 die annually, making HAIs the sixth leading cause of death in the United States. Moreover, the increasing number of HAIs caused by multiple-drug
resistant organisms (i.e., MRSA) leads to added morbidity, mortality, and costs. The optimal approach for preventing HAIs, including MRSA in hospital
settings, is unknown. Despite significant efforts in VA to prevent MRSA, 13% of Veterans admitted to acute care hospitals are colonized with MRSA, twice
the national average, and 58% of Veterans residing in VA community-living centers are colonized. CADRE HAI prevention research is centered around the
CREATE titled "Advancing MRSA Infection Prevention," and other studies that target new emerging pathogens (i.e., carbepenem-resistant Klebsiella
pneumonia), as well as infections that manifest beyond hospital settings and that are largely ignored by current surveillance and prevention efforts. This
work will be highly coordinated with key operations partners, including VA's Office of Public Health and VA's
National Center for Occupational Health and Infection Control (COHIC).
Each COIN works closely with a number of operational partners throughout the VA healthcare system. Cadre's partners include:
Office of Rural Health (ORH):Gina Capra, Director, and Michael Ohl, Director, VA Rural Health Resource Center,
- Office of Public Health
- Lewis Radonovich, M.D.
, Director, Center for Occupational Health and Infection Control
- National Infectious Diseases Services: Gary Roselle, M.D., Director
- VA Office of High Reliability Systems and Consultation: Mike Davies, M.D., Acting Director
- Veterans Integrated Service Network (VISN) 23: Janet Murphy, M.B.A., Director
- VISN 23 PACT Demonstration Lab: Gary Rosenthal, M.D., Director
- Iowa City VA Health Care System: Judith Johnson-Mekota, Director